Miniaturization has become a key strategy in modern assay development — reducing reagent consumption, increasing throughput, ...

Frederik Huhn and Dr. Katharina Haft discuss how digital non‑contact dispensing is enabling miniaturized, sustainable liquid ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

Interested in learning more about assay design for primers and probes? Join us for this special Guardian of Your Science “Ask the Expert” webinar, hosted by field applications scientist Ben Avery. Ben ...

Next-generation biomarker discovery and diagnostics Bio-Techne combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion ...

Ibrahim Mahama’s Damang Gold Mine has delivered its first 110kg of gold to the Ghana Gold Board (GoldBod), led by Sammy ...

The RCMP charged the former CEO of RPX Gold (TSXV: RPX) on April 28 with fraud and forgery in connection with allegedly […] ...

Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.

Includes a continuous 105.45-metre central pegmatite interval; laboratory assays and mineralogical confirmation pending ...

UPPSALA, SE / ACCESS Newswire / April 30, 2026 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) - Biovica today announces that three posters including TKa measurements will be presented ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers ...